Advertisement

Pediatric Nephrology

, Volume 9, Supplement 1, pp S35–S39 | Cite as

Correlation of donor antigen-specific hyporeactivity with allogeneic microchimerism in kidney and lung recipients

  • Nancy L. Reinsmoen
  • Cynthia McSherry
  • Blanche Chavers
  • Marshall I. Hertz
  • Arthur J. Matas
Article

Abstract

Our previous studies indicate donor antigenspecific hyporeactivity is a useful marker for identifying solid organ transplant recipients at low risk for immunological complications; the hyporeactive subgroup experiences a lower incidence of chronic rejection. One purpose of the current study was to determine whether hyporeactivity could be identified in pediatric kidney recipients and whether it correlated with improved graft outcome. Of 18 pediatric kidney recipients tested, 6 (33%) had developed donor antigen-specific hyporeactivity. All 18 experienced good graft outcome. Second, we determined whether donor antigen-specific hyporeactivity correlates with peripheral blood microchimerism and outcome in adult kidney recipients. Our previous studies of lung recipients demonstrated development of obliterative bronchiolitis in recipients with microchimerism who remain responsive, but not in recipients who had become hyporesponsive to donor antigen. Preliminary results in our current study of 23 adult kidney recipients indicate microchimerism for 6 (26%): 4 hyporesponsive and 2 responsive to donor antigen. Microchimerism was not detected for 17 recipients: 6 hyporesponsive and 11 responsive to donor antigen. One hyporesponsive/chimeric patient and 4 recipients negative for both parameters have been diagnosed with biopsy-proven chronic rejection. In summary, both hyporeactivity and chimerism are found at a higher frequency in lung than kidney recipients. Unlike lung recipients, not all hyporesponsive kidney recipients had peripheral blood chimerism. Additional numbers are needed to determine if microchimerism correlates with donor antigen-specific hyporeactivity or graft outcome.

Key words

Donor antigen-specific hyporeactivity Allogeneic microchimerism Kidney recipients 

References

  1. 1.
    Leventhal JR, Reinsmoen NL, Matas AJ (1993) Impact of HLA matching on acute and chronic rejection and transplant survival: a single institution's experience. Hum Immunol 37:79Google Scholar
  2. 2.
    Almond PS, Matas AJ, Gillingham KJ, Dunn DL, Payne WD, Gores P, Gruessner R, Najarian JS (1993) Risk factors for chronic rejection in renal allograft recipients. Transplantation 55:752–757PubMedCrossRefGoogle Scholar
  3. 3.
    Reinsmoen NL, Matas AJ, Kaufman D, Sutherland D, Najarian JS, Bach FH (1991) Acquired donor-specific hyporesponsiveness in long-term kidney allograft recipients. Transplant Proc 23: 141–142PubMedGoogle Scholar
  4. 4.
    Reinsmoen NL, Matas AJ (1993) Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 55:1017–1023PubMedCrossRefGoogle Scholar
  5. 5.
    Reinsmoen NL, Bolman RM, Savik K, Butters K, Matas AJ, Hertz MI (1995) Improved long-term graft outcome in lung transplant recipients who develop donor antigen-specific hyporeactivity. J Heart Lung Transplant (in press)Google Scholar
  6. 6.
    Strober S, Dhillon M, Schubert M, Holm B, Engelman E, Benike C, Hoppe R, Sibley R, Hyburgh JA, Collins G, Levin B (1989) Acquired immune tolerance to cadaveric renal allografts: a study of three patients treated with total lymphoid irradiation. N Engl J Med 321:28–33PubMedCrossRefGoogle Scholar
  7. 7.
    Goulmy E, Stijnen T, Groenewoud AF, Persijn G, Blockland E, Pool J, Paul L, Rood JJ van (1989) Renal transplant patients monitored by the cell-mediated lympholysis assay: evaluation of its clinical value. Transplantation 48:559–563PubMedCrossRefGoogle Scholar
  8. 8.
    Wramner L, Olausson M, Söderstrom T, Lindholm L, Rydberg L, Brynger H (1987) Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients. Transplantation 44:390–395PubMedCrossRefGoogle Scholar
  9. 9.
    Herzog WR, Zanker B, Irschick E, Huber C, Franz HE, Wagner H, Kabelitz D (1987) Selective reduction of donor-specific cytotoxic T lymphocyte precursors in patients with a well-functioning kidney allograft. Transplantation 43:384–389PubMedCrossRefGoogle Scholar
  10. 10.
    Cohen DJ, Lee HM, Mohanakumar T (1985) Mechanisms of CML hyporesponsiveness in long-term renal allograft recipients. Hum Immunol 14:279–286PubMedCrossRefGoogle Scholar
  11. 11.
    Thomas J, Johns C, Hoffmann S, Thomas F, Lee HM (1978) Suppressor cells inhibiting the generation of cytotoxic T lymphocytes in long-term human transplant recipients. Proc Dial Transplant Forum 7:87–89Google Scholar
  12. 12.
    Goulmy E, Persijn G, Blockland E, D'Amaro J, van Rood JJ (1981) Cell-mediated lympholysis studies in renal allograft recipients. Transplantation 31:210–217PubMedCrossRefGoogle Scholar
  13. 13.
    Liburd EM, Pazderka V, Kovithavongs T, Dossetor JB (1978) Evidence for suppressor cells and reduced CML induction by the donor in transplant patients. Transplant Proc 10:557–561PubMedGoogle Scholar
  14. 14.
    Thomas J, Thomas F, Mendez-Picon G, Lee H (1977) Immunological monitoring of long-surviving renal transplant recipients. Surgery 81:125–131PubMedGoogle Scholar
  15. 15.
    Charpentier BM, Lang P, Martin B, Fries D (1982) Specific recipient-donor unresponsiveness mediated by a suppressor cell system in human kidney allograft tolerance. Transplantation 33:470–477PubMedCrossRefGoogle Scholar
  16. 16.
    Saper V, Chow D, Engleman ED, Hoppe RT, Levin B, Collin G, Strober S (1988) Clinical and immunological studies of cadaveric renal transplant recipients given total-lymphoid irradiation and maintained on low-dose prednisone. Transplantation 45:540–546PubMedCrossRefGoogle Scholar
  17. 17.
    Chow D, Saper V, Strober S (1987) Renal transplant patients treated with total lymphoid irradiation show specific unresponsiveness to donor antigens in the mixed leukocyte reaction (MLR). J Immunol 138:3746–3750PubMedGoogle Scholar
  18. 18.
    Flechner SM, Kerman RH, Van Buren CT, Epps L, Kahan BD (1984) The use of cyclosporine in living-related renal transplantation: donor-specific hyporesponsiveness and steroid withdrawal. Transplantation 38:685–691PubMedCrossRefGoogle Scholar
  19. 19.
    Bach ML, Engstrom MA, Bach FH, Etheredge EE, Najarian JS (1972) Specific tolerance in human kidney allograft recipients. Cell Immunol 3:161–166PubMedCrossRefGoogle Scholar
  20. 20.
    Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M (1992) Cell migration, chimerism, and graft acceptance. Lancet 339:1579–1582PubMedCrossRefGoogle Scholar
  21. 21.
    Starzl TE, Demetris AJ, Trucco M, Ramos H, Zeevi A, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N (1992) Systemic chimerism in human female recipients of male livers. Lancet 340:876–877PubMedCrossRefGoogle Scholar
  22. 22.
    Starzl TE, Demetris AJ, Trucco M, Ricordi C, Ildstad S, Terasaki PI, Murase N, Kendall RS, Kocova M, Rudert WA, Zeevi A, Van Thiel D (1993) Chimerism after liver transplantation for type IV glycogen storage discase and type 1 Gaucher's disease. New Engl J Med 328:745–749PubMedCrossRefGoogle Scholar
  23. 23.
    Barber WH, Mankin JA, Laskow DA, Dierhoi MH, Julian BA, Curtis JJ, Diethelm AG (1991) Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 51:70–75PubMedCrossRefGoogle Scholar
  24. 24.
    Starzl TE, Demetris AJ, Trucco M, Zeevi A, Ramos H, Terasaki P, Rudert WA, Kocova M, Ricordi C, Ildstad S, Murase N (1993) Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation 55:1272–1277PubMedCrossRefGoogle Scholar
  25. 25.
    Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R (1993) Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation 56:951–955PubMedCrossRefGoogle Scholar
  26. 26.
    Schlitt HJ, Hundrieser J, Ringe B, Pichmayr R (1994) Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 330:646–647PubMedCrossRefGoogle Scholar
  27. 27.
    Reinsmoen NL, Mickelson EM (1990) HLA-Dw typing. In: Zachary AA (ed) The ASHI procedure manual. ASHI, Cleveland, pp 357–371Google Scholar
  28. 28.
    Yousem SA, Burke CM, Billingham ME (1988) Pathologic pulmonary alterations in long-term human heart-lung transplantation. Ann Surg 208:371PubMedCrossRefGoogle Scholar
  29. 29.
    Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39:225–235PubMedCrossRefGoogle Scholar
  30. 30.
    Slavin S, Strober S, Fuks Z, Kaplan HS (1977) Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J Exp Med 146:34–48PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 1995

Authors and Affiliations

  • Nancy L. Reinsmoen
    • 1
  • Cynthia McSherry
    • 1
  • Blanche Chavers
    • 2
  • Marshall I. Hertz
    • 3
  • Arthur J. Matas
    • 1
  1. 1.Department of SurgeryUniversity of MinnesotaMinneapolisUSA
  2. 2.Department of Pediatric NephrologyUniversity of MinnesotaMinneapolisUSA
  3. 3.Department of MedicineUniversity of MinnesotaMinneapolisUSA

Personalised recommendations